AXIL 703

Hazard statements (CLP)

H317, H319, H336, H351

Code

Statements

H317

May cause an allergic skin reaction

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

Suspected of causing cancer. May cause drowsiness allergy or asthma symptoms or breathing difficulties if or dizziness. May cause an allergic skin reaction. Causes serious eye irritation. May cause inhaled

Hazard pictograms

GHS07 GHS08

Signal word

Warning

Contains

ETHYL METHYL KETONE; DICHLOROMETHANE

Hazard statements

H319 - Causes serious eye irritation. H336 - May cause drowsiness or dizziness. H351 - Suspected of causing cancer.

Precautionary statements

P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. P264 - Wash hands, forearms and face thoroughly after handling. P271 - Use only outdoors or in a well-ventilated area. P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing protection. P304+P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308+P313 - IF exposed or concerned: Get medical advice/attention. P312 - Call a POISON CENTRE or doctor if you feel unwell. P337+P313 - If eye irritation persists: Get medical advice/attention. P403+P233 - Store in a well-ventilated place. Keep container tightly closed. P405 - Store locked up. P501 - Dispose of contents/container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation.

Supplemental label elements

EUH066 - Repeated exposure may cause skin dryness or cracking.

2.3 Other hazards

Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % Component DICHLOROMETHANE(75-09-2) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [CLP] Serious eye damage/eye irritation, Category 2 H319 Carcinogenicity, Category 2 H351 Specific target organ toxicity – Single exposure, Category 3, H336 Narcosis Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects Suspected of causing cancer. May cause drowsiness or dizziness. May cause an allergic skin reaction. Causes serious eye irritation. May cause allergy or asthma symptoms or breathing difficulties if inhaled.